Valeant Completes $1 Billion Notes Offering
Date: 11/23/10
Cahill represented the initial purchaser in a Rule 144A/Reg S Offering of $1 billion of 6.875% Senior Notes due 2018 by Valeant Pharmaceuticals International, Inc. Valeant intends to use the net proceeds from the offering of the Notes to repay its tranche B term loan facility under its credit facilities and for general corporate purposes.